Azithromycin, the active ingredient in Zithromax, can transfer to breast milk, though generally in low concentrations. This transfer poses a potential risk to the infant, primarily diarrhea and vomiting. The severity depends on several factors, including the mother’s dosage, the infant’s age and overall health, and the duration of treatment.
While rare, more serious side effects are possible, including allergic reactions. These are typically characterized by skin rashes, itching, or swelling. Immediate medical attention is crucial if your baby develops such symptoms.
Careful consideration must be given to the potential benefits of maternal treatment versus the potential risks to the infant. Your doctor will help assess this on a case-by-case basis.
| Mother’s Dose | Higher doses increase the amount of azithromycin transferred to breast milk. |
| Infant’s Age | Newborns and premature infants may be more susceptible to adverse effects. |
| Infant’s Health | Infants with pre-existing conditions may experience a heightened risk of complications. |
| Treatment Duration | Longer treatment courses result in greater exposure for the infant. |
Open communication with your pediatrician is key. They can monitor your baby’s health and adjust the treatment plan, potentially including alternative antibiotics if necessary, to minimize any potential harm.
Remember: This information serves as a guide and does not replace professional medical advice. Always consult with your healthcare provider before making decisions about medication use during breastfeeding.
